0 followers
Kalgene is developing a novel fusion protein therapeutic for slowing the progression of Alzheimer’s disease, with technology licensed from the National Research Council of Canada.
Industries
Headquarters
Stage
Employees
Links
View full screen
Nickolay V. Kukekov
View all
0 members
PharmaCielo
1 follower
Cannara Biotech
Aphria
3 followers
Khiron Life Sciences
Baylis Medical
Explore more companies
